Q2 2026 13F · SEC CIK 1802493

DCF Advisers, LLC

Asset managerFiled 2026-08-10 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value: $382.2M
Reported positions: 80
Top holdings a year, 3 yrs: +50.7%
Average holding period: 5.5 yrs

DCF Advisers, LLC is an asset manager that reported 80 positions worth $382.2M in its Q2 2026 13F, filed 2026-08-10. Its largest holdings were Micron Technology Inc (MU, 30.2%), Alphabet Inc (GOOG, 5.0%), Advanced Micro Devices Inc (AMD, 4.4%). A portfolio copying its top holdings returned 50.7% a year over the last 3 years, against 20.4% for the S&P 500.

DCF Advisers, LLC holdings largest 50 of 80 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

DCF Advisers, LLC 13F holdings
Stock	% of 13F value	Q1 2026	Shares	Share change	Reported value
MUMicron Technology Inc	30.2%	19.1%	100,000	-33.3%	$115.4M
GOOGAlphabet Inc	5.0%	6.2%	54,000	-5.3%	$19.1M
AMDAdvanced Micro Devices Inc	4.4%	2.2%	29,000	+0.0%	$16.8M
AMZNAmazon Com Inc	3.7%	3.0%	59,250	+55.9%	$14.1M
ARGNFArgenx SE	3.4%	4.0%	14,200	-3.1%	$13.2M
CRVSCorvus Pharmaceuticals Inc Com	2.5%	3.5%	637,500	+0.0%	$9.5M
23256X407Cybin Inc	2.5%	1.3%	1,434,988	+107.4%	$9.5M
TEVATeva Pharmaceutical Inds Ltd	2.3%	3.4%	254,500	-15.2%	$8.6M
MRVLMarvell Technology Inc	2.1%	1.0%	27,500	+0.0%	$8.2M
IAUIshares Gold Tr	2.0%	3.3%	100,000	+0.0%	$7.6M
BACBank of Amer Corp	1.8%	2.2%	119,500	+0.0%	$6.8M
REGNRegeneron Pharmaceuticals	1.5%	2.7%	9,250	+0.0%	$5.8M
ETPCEnergy Transfer L P	1.5%	2.2%	300,500	+0.0%	$5.7M
VRTXVertex Pharmaceuticals Inc	1.5%	1.2%	11,500	+64.3%	$5.7M
GLDSpdr Gold Tr	1.3%	1.9%	14,000	+16.7%	$5.2M
CCitigroup Inc	1.3%	1.5%	36,000	+0.0%	$5.0M
NAMSNewamsterdam Pharma Company Ordinary	1.3%	1.9%	141,000	-12.2%	$4.8M
GDXVaneck ETF Trust	1.2%	2.2%	62,500	+0.0%	$4.7M
INCYIncyte Corp	1.2%	1.5%	41,500	+0.0%	$4.7M
CSCOCisco Sys Inc	1.2%	1.6%	40,000	-27.3%	$4.7M
BIDUBaidu Inc	1.2%	1.7%	40,000	-2.4%	$4.6M
ORCLOracle Corp	1.2%	1.6%	30,500	+7.0%	$4.5M
ZMZoom Communications Inc	1.1%	1.4%	50,875	+9.4%	$4.4M
INTCIntel Corp	1.0%	0.6%	28,500	-18.6%	$4.0M
IMRXImmuneering Corp	1.0%	—	790,000	—	$3.9M
BABAAlibaba Group Hldg Ltd	1.0%	1.8%	39,500	+2.6%	$3.8M
MSFTMicrosoft Corp	0.9%	—	9,725	—	$3.6M
UBERUber Technologies Inc	0.9%	1.5%	50,000	-9.1%	$3.6M
LRCXLam Research Corp	0.8%	—	7,500	—	$3.2M
LLYEli Lilly & Co	0.8%	2.9%	2,700	-67.5%	$3.2M
EVOEvotec AG	0.8%	1.0%	1,079,024	+1.3%	$3.0M
IONSIonis Pharmaceuticals Inc	0.8%	1.6%	37,500	-33.0%	$3.0M
AODAbrdn Total Dynamic Dividend	0.7%	0.9%	266,000	+0.0%	$2.7M
ABBVAbbvie Inc	0.7%	0.9%	10,750	+0.0%	$2.7M
AVGOBroadcom Inc	0.7%	0.6%	7,125	+46.2%	$2.7M
ZBHZimmer Biomet Holdings Inc	0.7%	1.0%	30,500	+0.0%	$2.6M
JQCNuveen Cr Strategies Income	0.7%	0.9%	528,113	+10.9%	$2.6M
GDXJVaneck ETF Trust	0.6%	1.1%	25,000	+0.0%	$2.5M
LNDCLifecore Biomedical Inc	0.6%	0.6%	424,500	+0.0%	$2.2M
BBarrick Mng Corp	0.6%	—	60,000	—	$2.2M
SLVIshares Silver Tr	0.6%	1.0%	40,000	+0.0%	$2.1M
HZOMarinemax Inc	0.6%	—	57,500	—	$2.1M
BNEDBarnes & Noble Ed Inc	0.5%	0.7%	164,383	-16.5%	$2.1M
BHVNBiohaven Ltd	0.5%	—	130,000	—	$1.9M
AMGNAmgen Inc	0.5%	0.8%	5,250	-12.5%	$1.9M
QUREUniqure NV	0.5%	—	40,000	—	$1.8M
URNMSprott Fds Tr	0.5%	0.8%	35,000	+0.0%	$1.8M
GPCRStructure Therapeutics F Unspo	0.5%	0.5%	32,100	+16.7%	$1.7M
XNCRXencor Inc	0.4%	0.5%	103,736	+0.0%	$1.7M
AAPLApple Inc	0.4%	0.6%	5,750	+0.0%	$1.7M

What DCF Advisers, LLC bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year: +135.9% /yr; S&P 500 +20.1%
3 years: +50.7% /yr; S&P 500 +20.4%
5 years: +29.8% /yr; S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter	13F value	Positions
Q2 2026	$382.2M	80
Q1 2026	$265.3M	72
Q4 2025	$302.8M	75
Q3 2025	$264.0M	78
Q2 2025	$207.9M	74
Q1 2025	$185.8M	74
Q4 2024	$197.6M	78
Q3 2024	$191.8M	79
Q2 2024	$187.6M	81
Q1 2024	$162.5M	69
Q4 2023	$145.9M	69
Q3 2023	$141.4M	75

Questions about DCF Advisers, LLC's portfolio

What stocks does DCF Advisers, LLC own?

DCF Advisers, LLC's latest 13F, for Q2 2026 and filed Aug 10, 2026, lists 80 positions worth $382.2M. The largest are Micron Technology Inc (MU) at 30.2%, Alphabet Inc (GOOG) at 5.0%, Advanced Micro Devices Inc (AMD) at 4.4%, Amazon Com Inc (AMZN) at 3.7% and Argenx SE (ARGNF) at 3.4%.

What did DCF Advisers, LLC buy last quarter?

In Q2 2026, DCF Advisers, LLC added Cybin Inc (+107.4% shares), Vertex Pharmaceuticals Inc (VRTX) (+64.3% shares) and Amazon Com Inc (AMZN) (+55.9% shares), compared with its Q1 2026 filing.

What did DCF Advisers, LLC sell last quarter?

In Q2 2026, DCF Advisers, LLC cut from its top 50 Barrick Gold Corp, cut from its top 50 Lam Resh Corp (LRCX), cut from its top 50 Lyft Inc (LYFT), cut from its top 50 Qualcomm Inc (QCOM), cut from its top 50 Zai Lab Ltd (ZLAB), Eli Lilly & Co (LLY) (-67.5% shares), Micron Technology Inc (MU) (-33.3% shares) and Ionis Pharmaceuticals Inc (IONS) (-33.0% shares), compared with its Q1 2026 filing.

How has DCF Advisers, LLC's portfolio performed?

A portfolio copying DCF Advisers, LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +50.7% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +135.9% against +20.1%. Over 5 years: +29.8% a year against +11.6%.

When is DCF Advisers, LLC's next 13F filing due?

13F filings are due 45 days after each quarter ends. DCF Advisers, LLC's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.